4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
4-(3-溴苯基)-6,8-二氯-2-甲基-1,2,3,4-四氢异喹啉
Application
Tenapanor
CAS No. 543737-10-6
C₁₆H₁₄BrCl₂N
Therapeutic Area
11 intermediates
Area Overview
This catalog-derived group includes programs for acid suppression, intestinal fluid and electrolyte transport, hyperkalemia and urate management, as well as overactive-bladder therapy.
Classification is based on terminal APIs in the product catalog; product counts update with the catalog.
Representative Terminal APIs
11 catalog intermediates
4-(3-溴苯基)-6,8-二氯-2-甲基-1,2,3,4-四氢异喹啉
Application
Tenapanor
CAS No. 543737-10-6
C₁₆H₁₄BrCl₂N
2-(2-(2-氨基乙氧基)乙氧基)乙基氨基甲酸叔丁酯
Application
Tenapanor
CAS No. 153086-78-3
C₁₁H₂₄N₂O₄
(S)-4-(3-溴苯基)-6,8-二氯-2-甲基-1,2,3,4-四氢异喹啉
Application
Tenapanor
CAS No. 1870821-29-6
C₁₆H₁₄BrCl₂N
(1R,2R)-2-氨基-6-(4-硝基苯基)-1-苯基-5-炔-1-羟基盐酸盐
Application
Vibegron
CAS No. 1628836-08-7
C₁₈H₁₉ClN₂O₃
(6S)4,6,7,8-四氢-4-氧代吡咯并[1,2-A]嘧啶-6-羧酸
Application
Vibegron
CAS No. 1190392-22-3
C₈H₈N₂O₃
甲基2-氟丙烯酸酯
Application
Patiromer
CAS No. 2343-89-7
C₄H₅FO₂
2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸乙酯
Application
Febuxostat
CAS No. 160844-75-7
C₁₈H₂₀N₂O₃S
2-氯乙酰乙酸乙酯
Application
Febuxostat
CAS No. 609-15-4
C₆H₉ClO₃
2-[2-(2-氟苯基)-2-氧代乙基]丙二腈
Application
Vonoprazan
CAS No. 312307-38-3
C₁₁H₇FN₂O
5-(2-氟苯基)-1H-吡咯-3-甲醛
Application
Vonoprazan
CAS No. 881674-56-2
C₁₁H₈FNO
吡啶-3-磺酰氯盐酸盐
Application
Vonoprazan
CAS No. 16133-25-8
C₅H₄ClNO₂S
Need intermediates for this therapeutic area?
Ready to source? Our team responds to every inquiry within 24 hours.